As Tesla Inc TSLA explores an exit from the public markets, one Street analyst on Wednesday said Celgene Corporation CELG could pursue a similar path. RBC Capital analyst Brian Abrahams maintained an Outperform rating on Celgene with a $110 price target. SourceUpside potential is getting over. The price may go down and close the gap. $TSLA, Tesla, Inc. / D The price is ready to test the lower edge of the rising wedge soon and break it out. $CELG, Celgene Corporation / D